Board Vitals - Pharmacist

OCTOBER 23, 2022

Becoming a Family Medicine physician is a goal for thousands of medical students. According to the the American Association of Medical Colleges (AAMC) , Family Medicine is the second most popular medical specialty, and is chosen by approximately 8.5% of first-year medical residents for their residency training. . Like all medical specialties, becoming board certified in family medicine involves careful preparation—including studying for and passing the American Board of Family Medicine (ABFM) Ce

Medical Schools 98

Medical Schools Immunization 98

Drug Store News

OCTOBER 23, 2022

According to Cardinal Health's research, 76% of rheumatologists are "very familiar" with biosimilars, up from 53% in the 2020 report, and 62% are "very comfortable" prescribing biosimilars, compared to 41% in the 2020 report.

98

98

STAT

OCTOBER 23, 2022

The U.S. is less than three weeks from the 2022 midterm elections, which will decide which issues are prioritized — and then passed or defeated — in local, state, and federal governments. Medical professionals generally understand how election results can affect their personal freedoms, the health of the communities they serve and live in, and even how they practice medicine.

Hospitals 77

Hospitals 77

Drug Store News

OCTOBER 23, 2022

The assortment of products in reusable Loop containers will come from brands such as Kraft-Heinz, Nature's Path and Stubb's BBQ sauce.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Med Ed 101

OCTOBER 23, 2022

Z-drugs, otherwise known as benzodiazepine receptor agonists, are used to help patients with insomnia that is associated with difficulty falling asleep (sleep latency), difficulty staying asleep (sleep maintenance), or not feeling rested after a night’s sleep (sleep quality). While there aren’t a ton of differences, understanding sleep onset and subtle pharmacokinetic differences can help us best […].

59

59

Drug Store News

OCTOBER 23, 2022

Located in Greenburgh, N.Y., the new store will feature a variety of in-store shopping and pickup options.

98

98

Drug Store News

OCTOBER 23, 2022

Bondbar looks to help consumers achieve up to 70% reduced breakage during combing and up to 90% improvement in wet detangling, the company said.

75

75

Hospital Pharmacy Europe

OCTOBER 23, 2022

Inviting patients for screening colonoscopy has been found to be associated with a significantly lower 10-year risk of colorectal cancer. Patients who agree to screening colonoscopy after being sent an invite, have a significantly reduced risk of developing colorectal cancer after 10 years according to the findings of a randomised trial by the NordICC study group.

Hospitals 40

Hospitals 40

Drug Store News

OCTOBER 23, 2022

Flu activity has doubled week over week, the retailer said.

98

98

BioPharm

OCTOBER 23, 2022

Monday, October 24, 2022 Session One : 9:30am EDT | 6:30am PDT | 2:30pm BST | 3:30pm CEST Session Two : 12:30pm EDT | 9:30am PDT | 5:30pm BST | 6:30pm CEST Are your analytical methods keeping up with the pace of new biotherapeutic drug modalities? Attend this symposium to ensure success!

40

40

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Store News

OCTOBER 23, 2022

Automation and technology companies are amplifying their product offerings and services.

75

75

BioPharm

OCTOBER 23, 2022

Many CDMOs outsource their nanoparticle supply chain, but in house manufacturing of nanoparticles at CDMOs is anticipated to create new market opportunities.

Vaccines 40

Vaccines 40

Drug Store News

OCTOBER 23, 2022

Kroger Health and Cardinal Health are teaming up once more for Drug Take Back events slated for Saturday, Oct. 29.

52

52

Pharmaceutical Technology

OCTOBER 23, 2022

In January 2022, the United Kingdom adopted ISO 10993-7:2008 / Amd 1:2019 as BS EN ISO 10993-7:2008 / A1:2022 without modification. Prior to the implementation of the revised standard, no obvious consideration was given to patient age when setting the appropriate limits for ethylene oxide residues in medical devices. Arbitrary limits given as milligrams of exposure to residues per device were simply prescribed based on the physical contact time allowed for each category of device.

Packaging 40

Packaging 40

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

OCTOBER 23, 2022

The Japanese Ministry of Health, Labour and Welfare (MHLW) has agreed to review GSK ’s new drug application (NDA) for its respiratory syncytial virus (RSV) vaccine candidate for use in older adults. The proposed indication is for preventing RSV-caused lower respiratory tract diseases (LRTD) in adults aged 60 years and above. GSK made the submission based on the positive interim assessment findings from the multi-country, placebo-controlled, randomised, observer-blind Phase III AReSVi-006 clinica

Vaccines 40

Vaccines FDA 40